Summit Therapeutics Inc (SMMT) is near the bottom in its industry group according to InvestorsObserver. SMMT gets an overall rating of 40. That means it scores higher than 40 percent of stocks. Summit Therapeutics Inc gets a 31 rank in the Biotechnology industry. Biotechnology is number 19 out of 148 industries.
SMMT has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on SMMT!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 40 means the stock is more attractive than 40 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Summit Therapeutics Inc Stock Today?
Summit Therapeutics Inc (SMMT) stock is trading at $4.40 as of 10:10 AM on Thursday, Mar 28, a gain of $0.65, or 17.33% from the previous closing price of $3.75. The stock has traded between $4.19 and $4.60 so far today. Volume today is low. So far 924,364 shares have traded compared to average volume of 2,448,902 shares.
Click Here to get the full Stock Report for Summit Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
